Advanced search
Publication Cover
OncoImmunology Volume 10, 2021 - Issue 1
Submit an article Journal homepage
3,234
Views
36
CrossRef citations to date
0
Altmetric
Original Research

Integrated analyses of m1A regulator-mediated modification patterns in tumor microenvironment-infiltrating immune cells in colon cancer

Yuzhen Gaoa Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China;b Biomedical Research Center, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaView further author information
,
Hao Wangc Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China;d Institution of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang, ChinaView further author information
,
Huiming Lie Department of Clinical Laboratory, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, ChinaView further author information
,
Xinxin Yef School of Public Health, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, ChinaView further author information
,
Yan Xiaa Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China;b Biomedical Research Center, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaView further author information
,
Shijin Yuana Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China;b Biomedical Research Center, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaView further author information
,
Jie Lua Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China;b Biomedical Research Center, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaView further author information
,
Xinyou Xiea Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China;b Biomedical Research Center, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaCorrespondence[email protected]
View further author information
,
Liangjing Wangc Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China;d Institution of Gastroenterology, Zhejiang University, Hangzhou, Zhejiang, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8227-8855View further author information
ORCID Icon &
Jun Zhanga Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China;b Biomedical Research Center, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 1936758 | Received 15 Apr 2021, Accepted 26 May 2021, Published online: 23 Jun 2021

Citations (36)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Weiwei He, Bin Wang, Jikai He, Youcai Zhao & Wei Zhao. (2022) SSR4 as a prognostic biomarker and related with immune infiltration cells in colon adenocarcinoma. Expert Review of Molecular Diagnostics 22:2, pages 223-231.
Read now

Articles from other publishers (35)

Xiong Tian, Dali Hu, Na Wang, Lele Zhang & Xuequan Wang. (2024) LINC01614 is a promising diagnostic and prognostic marker in HNSC linked to the tumor microenvironment and oncogenic function. Frontiers in Genetics 15.
Crossref
Chao Ma, Zhuoyu Gu & Yang Yang. (2024) Development of m6A/m5C/m1A regulated lncRNA signature for prognostic prediction, personalized immune intervention and drug selection in LUAD. Journal of Cellular and Molecular Medicine 28:8.
Crossref
Ahmed M.M. Shaker, Mai I. Shahin, Asmaa M. AboulMagd, Hamdy M. Abdel-Rahman & Dalal A. Abou El Ella. (2024) Design, synthesis, and molecular docking of novel 1,3, 4-triaryl pyrazole derivatives bearing methylsulfonyl moiety with anticancer activity through dual targeting CDK2 and COX-2 enzymes. Journal of Molecular Structure 1301, pages 137323.
Crossref
Kunjian Lei, Yilei Sheng, Min Luo, Junzhe Liu, Chuandong Gong, Shigang Lv, Wei Tu, Minhua Ye, Miaojing Wu, Bing xiao, Hua Fang, Haitao Luo, Xinjun Liu, Xiaoyan Long, Xingen Zhu, Kai Huang & Jingying Li. (2024) Comprehensive analyses of m1A regulator-mediated modification patterns determining prognosis in lower-grade glioma (running title: m1A in LGG). Heliyon 10:6, pages e27510.
Crossref
Xiaofeng Chang, Jinhong Zhu, Rui-Xi Hua, Changmi Deng, Jiao Zhang, Jiwen Cheng, Suhong Li, Haixia Zhou, Jing He & Huanmin Wang. (2023) TRMT6 gene rs236110 C > A polymorphism increases the risk of Wilms tumor. Gene 882, pages 147646.
Crossref
Ensi Ma, Jianhua Li, Conghuan Shen, Yange Gu, Xinju Zhang, Li Li, Jing Zhao & Zhengxin Wang. (2023) The m6A-related gene signature stratifies poor prognosis patients and characterizes immunosuppressive microenvironment in hepatocellular carcinoma. Frontiers in Immunology 14.
Crossref
Yao Zhang, Ying Chen & Wen Wen. (2023) Four types of adenine-related RNA modification writers -mediated molecular subtypes contribute to predicting clinical outcomes and treatment options in bladder cancer. Frontiers in Immunology 14.
Crossref
Qiling Tang, Lvyuan Li, Yumin Wang, Pan Wu, Xiangchan Hou, Jiawei Ouyang, Chunmei Fan, Zheng Li, Fuyan Wang, Can Guo, Ming Zhou, Qianjin Liao, Hui Wang, Bo Xiang, Weihong Jiang, Guiyuan Li, Zhaoyang Zeng & Wei Xiong. (2023) RNA modifications in cancer. British Journal of Cancer 129:2, pages 204-221.
Crossref
Yuzhen Gao, Shipeng Chen, Hao Wang, Chenghao Wu, Rui An, Guoli Li, Min Yang, Ying Zhou, Yundong Zhou, Xinyou Xie, Hong Yu & Jun Zhang. (2023) Liver metastases across cancer types sharing tumor environment immunotolerance can impede immune response therapy and immune monitoring. Journal of Advanced Research.
Crossref
Yu Xiao, Jinluan Li & Junxin Wu. (2023) Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma. BMC Medical Genomics 16:1.
Crossref
Yuxin Kong, Jie Yu, Shengfang Ge & Xianqun Fan. (2023) Novel insight into RNA modifications in tumor immunity: Promising targets to prevent tumor immune escape. The Innovation 4:4, pages 100452.
Crossref
Jinyong He, Cuicui Xiao, Cuiping Li, Fan Yang & Cong Du. (2023) Integrative analysis of bulk and single-cell RNA sequencing data reveals distinct subtypes of MAFLD based on N1-methyladenosine regulator expression. Liver Research 7:2, pages 145-155.
Crossref
Feng Qi, Jia Li, Zhuoran Qi, Bin Zhou, Biwei Yang, Jun Zhang & Wenxing Qin. (2023) Modeling cross‐talk of RNA modification enzymes reveals tumor microenvironment‐associated clinical significance and immunotherapy prediction in hepatobiliary malignancy. MedComm 4:3.
Crossref
Jing Yang, Jin Xu, Wei Wang, Bo Zhang, Xianjun Yu & Si Shi. (2023) Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets. Signal Transduction and Targeted Therapy 8:1.
Crossref
Olivia Marx, Marc Mankarious & Gregory Yochum. (2023) Molecular genetics of early-onset colorectal cancer. World Journal of Biological Chemistry 14:2, pages 13-27.
Crossref
Rixin Zhang, Wenqiang Gan, Jinbao Zong, Yufang Hou, Mingxuan Zhou, Zheng Yan, Tiegang Li, Silin Lv, Zifan Zeng, Weiqi Wang, Fang Zhang & Min Yang. (2023) Developing an m5C regulator–mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer. Frontiers in Immunology 14.
Crossref
Jia Li, Dongwei Liu, Jingjing Ren, Guangpu Li, Zihao Zhao, Huanhuan Zhao, Qianqian Yan, Jiayu Duan & Zhangsuo Liu. (2023) Integrated analysis of RNA methylation regulators crosstalk and immune infiltration for predictive and personalized therapy of diabetic nephropathy. Human Genomics 17:1.
Crossref
Yuzhen Gao, Hao Wang, Shipeng Chen, Rui An, Yadong Chu, Guoli Li, Yanzhong Wang, Xinyou Xie & Jun Zhang. (2022) Single-cell N6-methyladenosine regulator patterns guide intercellular communication of tumor microenvironment that contribute to colorectal cancer progression and immunotherapy. Journal of Translational Medicine 20:1.
Crossref
Huimin Liu, Dongxu Wang, Zhijing Yang, Shuangji Li, Han Wu, Jingcheng Xiang, Shaoning Kan, Ming Hao & Weiwei Liu. (2022) Regulation of epigenetic modifications in the head and neck tumour microenvironment. Frontiers in Immunology 13.
Crossref
Wei Wei, Chao Liu, Caihong Wang, Meng Wang, Wei Jiang, Yaqian Zhou & Shuqun Zhang. (2022) Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy. Frontiers in Genetics 13.
Crossref
Shijin Yuan, Yuzhen Gao, Yan Xia, Zhuo Wang & Xian Wang. (2022) DNA methylation regulator-mediated modification pattern defines tumor microenvironment immune infiltration landscape in colon cancer. Frontiers in Genetics 13.
Crossref
Xinyue Zhang, Yuanlin Wang, Beibei Dong, Yi Jiang, Dan Liu, Keliang Xie & Yonghao Yu. (2022) Expression pattern and clinical value of Key RNA methylation modification regulators in ischemic stroke. Frontiers in Genetics 13.
Crossref
Shouzheng Ma, Jun Zhu, Mengmeng Wang, Jianfei Zhu, Wenchen Wang, Yanlu Xiong, Runmin Jiang, Lei Liu & Tao Jiang. (2022) Comprehensive analysis of m7G modification patterns based on potential m7G regulators and tumor microenvironment infiltration characterization in lung adenocarcinoma. Frontiers in Genetics 13.
Crossref
Lian Cui, Rui Ma, Jiangluyi Cai, Chunyuan Guo, Zeyu Chen, Lingling Yao, Yuanyuan Wang, Rui Fan, Xin Wang & Yuling Shi. (2022) RNA modifications: importance in immune cell biology and related diseases. Signal Transduction and Targeted Therapy 7:1.
Crossref
Hao Lu, Li-Yan Zheng, Ling-Yan Wu, Jun Chen, Na Xu & Sui-Cai Mi. (2022) The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma. Frontiers in Oncology 12.
Crossref
Maoshu Zhu, Chaoqun Huang, Xinhong Wu, Ying Gu, Xiaoxu Hu, Dongna Ma & Weimin Zhong. (2022) Aging-based molecular classification and score system in ccRCC uncovers distinct prognosis, tumor immunogenicity, and treatment sensitivity. Frontiers in Immunology 13.
Crossref
Hongbin Zhang, Zaifa Hong, Peipei Li, Han Jiang, Pengfei Wu & Jinzhong Chen. (2022) Identification and Validation of an Immune Evasion Molecular Subgroup of Patients With Colon Cancer for Implications of Immunotherapy. Frontiers in Genetics 13.
Crossref
Xiaolin Qu, Yongqiu Zhang, Xianzheng Sang, Ding Ren, Hong Zhao & Stephen T. C. Wong. (2022) Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer. Cancers 14:13, pages 3195.
Crossref
Yihao Wu, Deying Jiang, Hao Zhang, Fanxing Yin, Panpan Guo, Xiaoxu Zhang, Ce Bian, Chen Chen, Shuixin Li, Yuhan Yin, Dittmar Böckler, Jian Zhang & Yanshuo Han. (2022) N1-Methyladenosine (m1A) Regulation Associated With the Pathogenesis of Abdominal Aortic Aneurysm Through YTHDF3 Modulating Macrophage Polarization. Frontiers in Cardiovascular Medicine 9.
Crossref
Wu Xiong, Cong Li, Bowen Wan, Ziyang Zheng, Yingfei Zhang, Siming Wang & Jin Fan. (2022) N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma. Frontiers in Immunology 13.
Crossref
Youyuan Yang, Yue Tian, Qing Li, Rui Jiang & Junfeng Zhang. (2022) Uncovering the Immune Cell Infiltration Landscape in Low-Grade Glioma for Aiding Immunotherapy. Journal of Oncology 2022, pages 1-13.
Crossref
Shichao Zhang, Yu Xiong, Chaochao Zheng, Jinhua Long, Houming Zhou, Zhu Zeng, Yan Ouyang & Fuzhou Tang. (2022) Crosstalk Between Four Types of RNA Modification Writers Characterizes the Tumor Immune Microenvironment Infiltration Patterns in Skin Cutaneous Melanoma. Frontiers in Cell and Developmental Biology 10.
Crossref
Wenhao Ouyang, Yupeng Jiang, Shiyi Bu, Tiantian Tang, Linjie Huang, Ming Chen, Yujie Tan, Qiyun Ou, Luhui Mao, Yingjie Mai, Herui Yao, Yunfang Yu & Xiaoling Lin. (2022) A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology 9.
Crossref
Jiexin Li, Haisheng Zhang & Hongsheng Wang. (2022) N1-methyladenosine modification in cancer biology: Current status and future perspectives. Computational and Structural Biotechnology Journal 20, pages 6578-6585.
Crossref
Beibei Wang, Lihua Niu, Zhengyang Wang & Zhihua Zhao. (2021) RNA m1A Methyltransferase TRMT6 Predicts Poorer Prognosis and Promotes Malignant Behavior in Glioma. Frontiers in Molecular Biosciences 8.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.